C7*9, a new frequent C7 allele detected by an allotype-specific monoclonal antibody

Complement Inflamm. 1990;7(4-6):290-7. doi: 10.1159/000463163.

Abstract

Two sandwich ELISA for the quantitation of C7 in human plasma--one based on a monoclonal (MAb), the other performed with a polyclonal anti-C7 IgG--were established. Results from ELISA as well as from isoelectric focussing and immunoblotting with both antibodies revealed that the MAb is directed to an allotypic epitope on C7. About 6.7% of the plasma samples did not react with this MAb. Since these findings cannot be explained by the known alleles, the existence of a new C7 allele, C7*9, was suggested, whose product C7-9 is not detected by the MAb. A gene frequency of 0.21 C7*9 was assumed. When using conventional techniques C7*9 is included in the frequency of C7*1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles*
  • Antibodies
  • Antibodies, Monoclonal
  • Complement C7 / analysis
  • Complement C7 / genetics*
  • Complement C7 / immunology
  • Enzyme-Linked Immunosorbent Assay
  • Gene Frequency
  • Humans
  • Immunoblotting
  • Isoelectric Focusing
  • Phenotype
  • Polymorphism, Genetic*

Substances

  • Antibodies
  • Antibodies, Monoclonal
  • Complement C7